National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:34:18

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
43598-220-28	EA - Each	43598-220	3d5be574-acff-4e3a-8e9f-24c8defd9e52	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
43598-220	43598-220-28

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050785-001	AUGMENTIN XR	AMOXICILLIN; CLAVULANATE POTASSIUM	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2002-09-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N050785-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2002-09-25	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2002-09-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2002-09-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2002-09-25	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2002-09-25	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2002-09-25	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2002-09-25	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N050785-001	AUGMENTIN XR	1GM;EQ 62.5MG BASE	TABLET, EXTENDED RELEASE / ORAL		RLD	2002-09-25	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N050785-001	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050785-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050785-001	AB	1	`011fe1cb6892…`
2019-12-13 00:20 UTC	2019-12	N050785-001	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N050785-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050785-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050785-001	AB	1	`ea99ee380514…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N050785-001	AB	1	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N050785-001	6746692	2020-04-04		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050785-001	6783773	2020-04-04		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050785-001	6878386	2020-04-04	U-926		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050785-001	7217430	2020-04-04	U-926	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050785-001	7250176	2020-04-04	U-926		`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N050785-001	6746692	2020-04-04		Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050785-001	6783773	2020-04-04		Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050785-001	6878386	2020-04-04	U-926		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050785-001	7217430	2020-04-04	U-926	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050785-001	7250176	2020-04-04	U-926		`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050785-001	6746692	2020-04-04		Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050785-001	6783773	2020-04-04		Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050785-001	6878386	2020-04-04	U-926		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050785-001	7217430	2020-04-04	U-926	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050785-001	7250176	2020-04-04	U-926		`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050785-001	6746692	2020-04-04		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050785-001	6783773	2020-04-04		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050785-001	6878386	2020-04-04	U-926		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050785-001	7217430	2020-04-04	U-926	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050785-001	7250176	2020-04-04	U-926		`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050785-001	6746692	2020-04-04		Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050785-001	6783773	2020-04-04		Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050785-001	6878386	2020-04-04	U-926		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050785-001	7217430	2020-04-04	U-926	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050785-001	7250176	2020-04-04	U-926		`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050785-001	6746692	2020-04-04		Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N050785-001	6783773	2020-04-04		Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N050785-001	6878386	2020-04-04	U-926		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N050785-001	7217430	2020-04-04	U-926	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N050785-001	7250176	2020-04-04	U-926		`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.